Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients

0 avis

Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients

Archive ouverte

Edité par CCSD ; Oxford University Press (OUP) -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Hydroxychloroquine in Coronavirus Disease 2019 Patients: What Still Needs to Be Known About the Kinetics

Archive ouverte | Martin-Blondel, Guillaume | CCSD

International audience. Different dosage regimens of hydroxychloroquine are used to manage coronavirus disease 2019 (COVID-19) patients, without information on the pharmacokinetics in this population. Blood samples ...

“De-Shrinking” EBEs: The Solution for Bayesian Therapeutic Drug Monitoring

Archive ouverte | Baklouti, Sarah | CCSD

International audience. Background Therapeutic drug monitoring (TDM) aims at individualising a dosage regimen and is increasingly being performed by estimating individual pharmacokinetic parameters via empirical Bay...

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation

Archive ouverte | Baklouti, Sarah | CCSD

International audience. Background: Pharmacokinetic models are evaluated using three types of metrics: those based on estimating the typical pharmacokinetic parameters, those based on predicting individual pharmacok...

Chargement des enrichissements...